SCHEMBL21281540

SCHEMBL21281540

BC1(N(C)Cc2c(C=O)cccc2NCc2ccc(C(O)(O)N3CCOCC3)cc2F)C(=O)NC(=O)C(O)(O)C1(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281570 0.87 MAPK14 (0.33) —
SCHEMBL23939274 0.79 DDB1 (0.35) —
SCHEMBL21924346 0.74 BDKRB1 (0.34) —
SCHEMBL21927110 0.71 CRBN (0.35) —
SCHEMBL21924070 0.69 BDKRB1 (0.30) —
SCHEMBL21281471 0.68 CRBN (0.35) —
SCHEMBL21924055 0.68 USP2 (0.31) —
SCHEMBL19310245 0.68 ERN1 (0.35) —
SCHEMBL21925035 0.67 DDB1 (0.34) —
SCHEMBL19310082 0.66 DDB1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3527210-A1 COMPOSITION, APPLICATION THEREOF AND TREATMENT METHOD Kangpu Biopharmaceuticals, Ltd. (CN) 2019-08-21 — — EP disclosed
Send feedback